Ariad Pharmaceuticals Inc (NASDAQ:ARIA)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar pavlos1971 (99.44) Submitted: 4/4/2013 9:44:00 AM : Outperform Start Price: $20.69 ARIA Score: -26.54

Got 1K@16.66 in RL this morning just at around the closing of the conference call. I liked Harvey's thumping his fist on the table at the end of the call, saying he wishes he could buy stock (even though he keeps selling himself). His suggestion of possessing material information that doesn't allow him to buy more stock sounded rather amateurish to me. At least I'm a little less concerned about the Favus report now, which had lead me to short the stock for a day yesterday. We will see which of these two positions would have been the better long-term option in a couple of months.

Featured Broker Partners


Advertisement